President Donald Trump called on Congress Thursday to take action to repeal and reform the impending hemp ban that would wipe out nearly all hemp-derived CBD products on the market. “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to

The order from the Department of Justice moves state-licensed medical marijuana from a Schedule I drug to Schedule III, which is less restrictive.

A surprise reclassification of medical marijuana to a less dangerous drug on Thursday has left many Marylanders with more questions than answers. Acting Attorney General Todd Blanche signed an order Thursday that would move medical marijuana from a Schedule I to a Schedule III drug,

President Trump's reclassification of medical marijuana marks a significant shift in federal policy, potentially paving the way for broader legalization and economic benefits for the cannabis industry.

U.S. Rep Veronica Escobar made a statement following the Trump Administration’s reclassifying medical marijuana as “less dangerous.” “I want to read exactly what is in the

Marijuana’s Schedule III shift could boost cannabis MSOs via new capital access and Section 280E tax relief. Read more here.

Akanda Corp. AKAN shares are trending on Thursday. AKAN shares climbed 33.69% to $13.65 after the bell on Wednesday. The after-hours gain follows a 214.15% surge during the regular session, which closed the medical cannabis and wellness company’s stock at $10.